Liver diseases associated with anti-tumo
โ
Carla S. Coffin; Hughie F. Fraser; Remo Panaccione; Subrata Ghosh
๐
Article
๐
2011
๐
John Wiley and Sons
๐
English
โ 90 KB
๐ 1 views
The conventional treatment of inflammatory bowel disease (IBD) has focused on nonspecifically targeting mucosal inflammation. In the last decade, with the advent of novel biological agents that directly inhibit proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-a), rapid progress ha